NCT07162480
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +4 more
- Locations
-
- The University of Texas M. D. Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Carcinoma, Adenoid Cystic
Explore clinical trials studying Carcinoma, Adenoid Cystic. Study availability and eligibility vary by location and protocol.
60 public trials
19 recruiting studies
Carcinoma, Adenoid Cystic trial results
NCT05774899
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +6 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT06891560
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +4 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Center Suffolk - Commack (All Protocol Activities) Commack, New York, United States
NCT07522879
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +5 more
- Locations
-
- Eye & ENT Hospital of Fudan University Shanghai, China
NCT05377996
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +34 more
- Locations
-
- Mayo Clinic Comprehensive Cancer Center Phoenix, Arizona, United States
- UC Irvine Health-Chao Family Comprehensive Cancer Center Orange, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology Santa Monica, California, United States
Recruiting
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
NCT06118086
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +6 more
- Locations
-
- University of California San Francisco Helen Diller Comprehensive Cancer Center San Francisco, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Dana Farber Cancer Research Institute Boston, Massachusetts, United States
- University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States
NCT07652489
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +5 more
- Locations
-
- The Second Affiliated Hospital of Harbin Medical University Harbin, Heilongjiang, China
- Third Xiangya Hospital, Central South University Changsha, Hunan, China
- The First Affiliated Hospital of China Medical University Shenyang, Liaoning, China
- Eye & ENT Hospital of Fudan University Shanghai, Shanghai Municipality, China
NCT07320508
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +6 more
- Locations
-
- Eye and ENT Hospital, Fudan University Shanghai, Xuhui Strict, China
Recruiting
Agnostic Therapy in Rare Solid Tumors
NCT06638931
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +131 more
- Locations
-
- Hospital São Carlos Fortaleza, Ceará, Brazil
- Hospital São Rafael Salvador, Estado de Bahia, Brazil
- Hospital Santa Cruz Curitiba, Paraná, Brazil
- IDOR Recife Recife, Pernambuco, Brazil
NCT03556228
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Adenoma, +65 more
- Locations
-
- Providence Medical Foundation (site 209) Santa Rosa, California, United States
- Hartford Hospital (site 210) Hartford, Connecticut, United States
- The George Washington University Cancer Center (site 212) Washington D.C., District of Columbia, United States
- Holy Cross Hospital (site 213) Fort Lauderdale, Florida, United States